Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 119.00K | 80.00K | 46.00K | 152.00K | 165.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.00K | 80.00K | 46.00K | 152.00K | 165.00K |
| Cost of Revenue | 276.00K | 142.00K | 61.00K | 257.00K | 304.00K |
| Gross Profit | -157.00K | -62.00K | -15.00K | -105.00K | -139.00K |
| SG&A Expenses | 1.51M | 3.02M | 2.38M | 1.58M | 2.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.79M | 4.48M | 3.98M | 3.83M | 4.50M |
| Operating Income | -1.67M | -4.40M | -3.94M | -3.68M | -4.34M |
| Income Before Tax | -1.63M | -4.33M | -3.43M | -3.65M | -4.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.63M | -4.33M | -3.43M | -3.65M | -4.33M |
| Earnings from Discontinued Operations | -- | -152.00K | -830.00K | 184.00K | -1.48M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.63M | -4.48M | -4.26M | -3.46M | -5.81M |
| EBIT | -1.67M | -4.40M | -3.94M | -3.68M | -4.34M |
| EBITDA | -1.63M | -4.28M | -3.81M | -3.56M | -4.20M |
| EPS Basic | -0.26 | -0.72 | -0.72 | -0.59 | -0.99 |
| Normalized Basic EPS | -0.16 | -0.43 | -0.41 | -0.39 | -0.46 |
| EPS Diluted | -0.26 | -0.72 | -0.72 | -0.59 | -0.99 |
| Normalized Diluted EPS | -0.16 | -0.43 | -0.41 | -0.39 | -0.46 |
| Average Basic Shares Outstanding | 6.33M | 6.25M | 5.91M | 5.88M | 5.88M |
| Average Diluted Shares Outstanding | 6.33M | 6.25M | 5.91M | 5.88M | 5.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
